On 9 July 2014, Luye Pharma Group (02186.HK) (“Luye Pharma”) listed on the main board of Hong Kong Stock Exchange. Grandall Shanghai has been retained as legal advisor of the undertaking team (including Citigroup Global Market Asia Limited, UBS and CITIC Securities) for the IPO project of Luye Pharma. Ms. WU Xiaoliang, Ms. Wei Wei, Ms. ZHANG Jing, Ms. XIAO Jingkai, Ms. PAN Xiaoxiao and Ms. LI Guanwen acted as key lawyers servicing the case.
